Literature DB >> 9255856

The effect of language production manipulations on negative thought disorder and discourse coherence disturbances in schizophrenia.

D M Barch1, H Berenbaum.   

Abstract

This study was designed to test the following hypotheses about the mechanisms underlying language disturbances in schizophrenia: (1) negative thought disorder (reduced verbosity and syntactic complexity, increased pausing) reflects a deficit generating a discourse plan; and (2) discourse coherence disturbances (tangential responses, loss of goal, derailment, non-sequiturs, distractible speech) reflect a deficit maintaining a discourse plan. Thirty-nine participants with, DSM-III-R schizophrenia listened to two stories and answered a series of questions after each story. We manipulated two factors: (1) the presence of context before the stories (to influence generating a discourse plan); and (2) question type (structured vs. unstructured; designed to influence maintaining a discourse plan). Consistent with our hypotheses, low context was associated with less verbose and syntactically complex speech. In addition, patients produced more discourse coherence disturbances when responding to unstructured than when responding to structured questions.

Entities:  

Mesh:

Year:  1997        PMID: 9255856     DOI: 10.1016/s0165-1781(97)00045-0

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

Review 1.  What do we really know about blunted vocal affect and alogia? A meta-analysis of objective assessments.

Authors:  Alex S Cohen; Kyle R Mitchell; Brita Elvevåg
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

Review 2.  Language as a biomarker for psychosis: A natural language processing approach.

Authors:  Cheryl M Corcoran; Vijay A Mittal; Carrie E Bearden; Raquel E Gur; Kasia Hitczenko; Zarina Bilgrami; Aleksandar Savic; Guillermo A Cecchi; Phillip Wolff
Journal:  Schizophr Res       Date:  2020-06-01       Impact factor: 4.939

3.  Cognitive control components and speech symptoms in people with schizophrenia.

Authors:  Theresa M Becker; David C Cicero; Nelson Cowan; John G Kerns
Journal:  Psychiatry Res       Date:  2012-02-22       Impact factor: 3.222

Review 4.  Paradigms for Assessing Hedonic Processing and Motivation in Humans: Relevance to Understanding Negative Symptoms in Psychopathology.

Authors:  Deanna M Barch; James M Gold; Ann M Kring
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

5.  The normalities and abnormalities associated with speech in psychometrically-defined schizotypy.

Authors:  Alex S Cohen; Tracey L Auster; Jessica E McGovern; Rebecca K MacAulay
Journal:  Schizophr Res       Date:  2014-10-29       Impact factor: 4.939

6.  Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia.

Authors:  Zainab Delawalla; Deanna M Barch; Jennifer L Fisher Eastep; Emily S Thomason; Melissa J Hanewinkel; Paul A Thompson; John G Csernansky
Journal:  Schizophr Bull       Date:  2006-05-19       Impact factor: 9.306

7.  Cognitive correlates of schizophrenia signs and symptoms: I. Verbal communication disturbances.

Authors:  Howard Berenbaum; John G Kerns; Laura L Vernon; Jose J Gomez
Journal:  Psychiatry Res       Date:  2008-04-18       Impact factor: 3.222

Review 8.  Using Language Processing and Speech Analysis for the Identification of Psychosis and Other Disorders.

Authors:  Cheryl Mary Corcoran; Guillermo A Cecchi
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-06-14

9.  Semantics, pragmatics, and formal thought disorders in people with schizophrenia.

Authors:  Carlos Salavera; Miguel Puyuelo; José L Antoñanzas; Pilar Teruel
Journal:  Neuropsychiatr Dis Treat       Date:  2013-02-07       Impact factor: 2.570

10.  Negative symptoms and speech pauses in youths at clinical high risk for psychosis.

Authors:  Emma R Stanislawski; Zarina R Bilgrami; Cansu Sarac; Sahil Garg; Stephen Heisig; Guillermo A Cecchi; Carla Agurto; Cheryl M Corcoran
Journal:  NPJ Schizophr       Date:  2021-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.